{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:12Z","timestamp":1772166012501,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HA23C0083"],"award-info":[{"award-number":["HA23C0083"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003050","name":"Ministry of Economy, Trade and Industry","doi-asserted-by":"publisher","award":["RS-2025-02220286"],"award-info":[{"award-number":["RS-2025-02220286"]}],"id":[{"id":"10.13039\/501100003050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-03323-x","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T14:34:26Z","timestamp":1768660466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver cancer risk stratification using deep learning on nationwide longitudinal health screening data: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0988-758X","authenticated-orcid":false,"given":"Yewon","family":"Choi","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1784-8685","authenticated-orcid":false,"given":"Sungmin","family":"Cho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-7220","authenticated-orcid":false,"given":"Changdai","family":"Gu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8508-7084","authenticated-orcid":false,"given":"Chungho","family":"Kim","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-9975","authenticated-orcid":false,"given":"Bomi","family":"Park","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-8973","authenticated-orcid":false,"given":"Hwiyoung","family":"Kim","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"3323_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3323_CR2","doi-asserted-by":"publisher","first-page":"e2445525","DOI":"10.1001\/jamanetworkopen.2024.45525","volume":"7","author":"S Qiu","year":"2024","unstructured":"Qiu S, Cai J, Yang Z, et al. Trends in hepatocellular carcinoma mortality rates in the US and projections through 2040. JAMA Netw Open. 2024;7:e2445525\u20132445525.","journal-title":"JAMA Netw Open"},{"key":"3323_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156:477\u2013e4911.","journal-title":"Gastroenterology"},{"key":"3323_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4143\/crt.2019.138","volume":"51","author":"K-W Jung","year":"2019","unstructured":"Jung K-W, Won Y-J, Kong H-J, Lee ES. Cancer statistics in korea: Incidence, Mortality, Survival, and prevalence in 2016. Cancer Res Treat. 2019;51:417\u201330.","journal-title":"Cancer Res Treat"},{"key":"3323_CR5","doi-asserted-by":"crossref","unstructured":"Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Korean J Radiol. 2022;23:1126\u20131240.","DOI":"10.3348\/kjr.2022.0822"},{"key":"3323_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/hep.32434","volume":"77","author":"F Kanwal","year":"2023","unstructured":"Kanwal F, Khaderi S, Singal AG, et al. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatol Baltim Md. 2023;77:997\u20131005.","journal-title":"Hepatol Baltim Md"},{"key":"3323_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatol Baltim Md. 2021;73:4\u201313.","journal-title":"Hepatol Baltim Md"},{"key":"3323_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/joim.13570","volume":"293","author":"J Vaz","year":"2023","unstructured":"Vaz J, Str\u00f6mberg U, Midl\u00f6v P, Eriksson B, Buchebner D, Hagstr\u00f6m H. Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients. J Intern Med. 2023;293:184\u201399.","journal-title":"J Intern Med"},{"key":"3323_CR9","doi-asserted-by":"publisher","first-page":"e2454707","DOI":"10.1001\/jamanetworkopen.2024.54707","volume":"8","author":"P Le","year":"2025","unstructured":"Le P, Tatar M, Dasarathy S, et al. Estimated burden of metabolic Dysfunction\u2013Associated steatotic liver disease in US Adults, 2020 to 2050. JAMA Netw Open. 2025;8:e2454707.","journal-title":"JAMA Netw Open"},{"key":"3323_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","volume":"79","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME. Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease. Hepatol Baltim Md. 2024;79:1212\u20139.","journal-title":"Hepatol Baltim Md"},{"key":"3323_CR11","doi-asserted-by":"publisher","first-page":"e252208","DOI":"10.1001\/jamanetworkopen.2025.2208","volume":"8","author":"PS Pinheiro","year":"2025","unstructured":"Pinheiro PS, Zhang J, Setiawan VW, Cranford HM, Wong RJ, Liu L. Liver cancer etiology in Asian subgroups and American Indian, Black, Latino, and white populations. JAMA Netw Open. 2025;8:e252208.","journal-title":"JAMA Netw Open"},{"key":"3323_CR12","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"3323_CR13","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","volume":"402","author":"M Serra-Burriel","year":"2023","unstructured":"Serra-Burriel M, Juanola A, Serra-Burriel F, et al. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study. Lancet. 2023;402:988\u201396.","journal-title":"Lancet"},{"key":"3323_CR14","doi-asserted-by":"publisher","first-page":"e2445533","DOI":"10.1001\/jamanetworkopen.2024.45533","volume":"7","author":"E Qayed","year":"2024","unstructured":"Qayed E. The evolving landscape of hepatocellular carcinoma mortality in the US. JAMA Netw Open. 2024;7:e2445533.","journal-title":"JAMA Netw Open"},{"key":"3323_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/s-0039-1677768","volume":"39","author":"F Trevisani","year":"2019","unstructured":"Trevisani F, Garuti F, Neri A. Alpha-fetoprotein for Diagnosis, Prognosis, and transplant selection. Semin Liver Dis. 2019;39:163\u201377.","journal-title":"Semin Liver Dis"},{"key":"3323_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12885-021-08498-w","volume":"21","author":"C An","year":"2021","unstructured":"An C, Choi JW, Lee HS, Lim H, Ryu SJ, Chang JH, Oh HC. Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort study. BMC Cancer. 2021;21:755.","journal-title":"BMC Cancer"},{"key":"3323_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","volume":"76","author":"HY Kim","year":"2022","unstructured":"Kim HY, Lampertico P, Nam JY, et al. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B. J Hepatol. 2022;76:311\u20138.","journal-title":"J Hepatol"},{"key":"3323_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JHC.S341045","volume":"9","author":"J Thomas","year":"2022","unstructured":"Thomas J, Liao LM, Sinha R, Patel T, Antwi SO. Hepatocellular carcinoma risk prediction in the NIH-AARP diet and health study cohort: A machine learning approach. J Hepatocell Carcinoma. 2022;9:69\u201381.","journal-title":"J Hepatocell Carcinoma"},{"key":"3323_CR19","doi-asserted-by":"publisher","first-page":"e2015626","DOI":"10.1001\/jamanetworkopen.2020.15626","volume":"3","author":"GN Ioannou","year":"2020","unstructured":"Ioannou GN, Tang W, Beste LA, Tincopa MA, Su GL, Van T, Tapper EB, Singal AG, Zhu J, Waljee AK. Assessment of a deep learning model to predict hepatocellular carcinoma in patients with hepatitis C cirrhosis. JAMA Netw Open. 2020;3:e2015626.","journal-title":"JAMA Netw Open"},{"key":"3323_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s44276-025-00141-6","volume":"3","author":"TMT Khong","year":"2025","unstructured":"Khong TMT, Bui TT, Kang H-Y, Park E, Ki M, Choi Y-J, Kim B, Oh J-K. Cancer risk according to lifestyle risk score trajectories: a population-based cohort study. BJC Rep. 2025;3:28.","journal-title":"BJC Rep"},{"key":"3323_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-025-02473-w","volume":"25","author":"V Moglia","year":"2025","unstructured":"Moglia V, Johnson O, Cook G, de Kamps M, Smith L. Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping review. BMC Med Res Methodol. 2025;25:24.","journal-title":"BMC Med Res Methodol"},{"key":"3323_CR22","first-page":"364","volume":"5","author":"S Sundrani","year":"2021","unstructured":"Sundrani S, Lu J. Computing the hazard ratios associated with explanatory variables using machine learning models of survival data. JCO Clin Cancer Inf. 2021;5:364\u201378.","journal-title":"JCO Clin Cancer Inf"},{"key":"3323_CR23","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong S, Kim Y-Y, Khang Y-H, et al. Data resource profile: the National health information database of the National health insurance service in South Korea. Int J Epidemiol. 2017;46:799\u2013800.","journal-title":"Int J Epidemiol"},{"key":"3323_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.23838\/pfm.2021.00135","volume":"6","author":"DW Shin","year":"2022","unstructured":"Shin DW, Cho J, Park JH, Cho B. National general health screening program in korea: history, current status, and future direction. Precis Future Med. 2022;6:9\u201331.","journal-title":"Precis Future Med"},{"key":"3323_CR25","doi-asserted-by":"crossref","unstructured":"Cho S, Park S, Lee SK, Oh SN, Kim KH, Ko A, Park SM. Associations of changes in alcohol consumption on the risk of depression\/suicide among initial nondrinkers. Depress Anxiety. 2024;2024:7560390.","DOI":"10.1155\/2024\/7560390"},{"key":"3323_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12916-024-03400-4","volume":"22","author":"H Park","year":"2024","unstructured":"Park H, Kim D, Jang E, et al. Modifiable lifestyle factors and lifetime risk of atrial fibrillation: longitudinal data from the Korea NHIS-HealS and UK biobank cohorts. BMC Med. 2024;22:194.","journal-title":"BMC Med"},{"key":"3323_CR27","doi-asserted-by":"publisher","unstructured":"Park B, Kim CH, Jun JK, Suh M, Choi KS, Choi IJ, Oh HJ. A machine learning risk prediction model for gastric cancer with SHapley additive explanations. Cancer Res Treat. https:\/\/doi.org\/10.4143\/crt.2024.843.","DOI":"10.4143\/crt.2024.843"},{"key":"3323_CR28","first-page":"e15","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee J, Lee JS, Park S-H, Shin SA, Kim K. Cohort profile: the National health insurance Service-National sample cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46:e15.","journal-title":"Int J Epidemiol"},{"key":"3323_CR29","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong SC, Kim Y-Y, Park SK, et al. Cohort profile: the National health insurance Service-National health screening cohort (NHIS-HEALS) in Korea. BMJ Open. 2017;7:e016640.","journal-title":"BMJ Open"},{"key":"3323_CR30","unstructured":"Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster BV, et al. TRIPOD+ AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385."},{"key":"3323_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/cncr.33940","volume":"128","author":"G Forjaz","year":"2022","unstructured":"Forjaz G, Howlader N, Scoppa S, Johnson CJ, Mariotto AB. Impact of including second and later cancers in Cause-Specific survival estimates using Population-based registry data. Cancer. 2022;128:547\u201357.","journal-title":"Cancer"},{"key":"3323_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.14701\/ahbps.23-053","volume":"27","author":"MJ Kang","year":"2023","unstructured":"Kang MJ, Lim J, Han S-S, Park HM, Cho SC, Park S-J, Kim S-W, Won Y-J. Exocrine pancreatic cancer as a second primary malignancy: A population-based study. Ann Hepato-Biliary-Pancreat Surg. 2023;27:415\u201322.","journal-title":"Ann Hepato-Biliary-Pancreat Surg"},{"key":"3323_CR33","doi-asserted-by":"crossref","unstructured":"Kim YR, Baek JY, Seo SH, Park H, Cho S, Shin A, et al. Operational definition of liver cancer in studies using data from the National Health Insurance Service: a systematic review. J Cancer Prev. 2023;28:47\u201352.","DOI":"10.15430\/JCP.2023.28.2.47"},{"key":"3323_CR34","doi-asserted-by":"publisher","unstructured":"Wang C, Deng C, Wang S. Imbalance-XGBoost: leveraging weighted and focal losses for binary label-imbalanced classification with XGBoost. 2021. https:\/\/doi.org\/10.48550\/arXiv.1908.01672.","DOI":"10.48550\/arXiv.1908.01672"},{"key":"3323_CR35","doi-asserted-by":"publisher","unstructured":"Lin T-Y, Goyal P, Girshick R, He K, Doll\u00e1r P. Focal loss for dense object detection. 2018. https:\/\/doi.org\/10.48550\/arXiv.1708.02002.","DOI":"10.48550\/arXiv.1708.02002"},{"key":"3323_CR36","first-page":"28","volume":"34","author":"WELCH BL","year":"1947","unstructured":"WELCH BL. THE GENERALIZATION OF \u2018STUDENT\u2019S\u2019 PROBLEM WHEN SEVERAL DIFFERENT POPULATION VARLANCES ARE INVOLVED. Biometrika. 1947;34:28\u201335.","journal-title":"Biometrika"},{"key":"3323_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1214\/aoms\/1177729380","volume":"23","author":"WG Cochran","year":"1952","unstructured":"Cochran WG. The $\\chi^2$ test of goodness of fit. Ann Math Stat. 1952;23:315\u201345.","journal-title":"Ann Math Stat"},{"key":"3323_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"3323_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47:458\u201372.","journal-title":"Biom J"},{"key":"3323_CR40","doi-asserted-by":"publisher","first-page":"c83","DOI":"10.1159\/000324758","volume":"119","author":"VS Stel","year":"2011","unstructured":"Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ. Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract. 2011;119:c83\u20138.","journal-title":"Nephron Clin Pract"},{"key":"3323_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and Life-Tables. J R Stat Soc Ser B Methodol. 1972;34:187\u2013220.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"3323_CR42","doi-asserted-by":"publisher","first-page":"e2443608","DOI":"10.1001\/jamanetworkopen.2024.43608","volume":"7","author":"YC Ilagan-Ying","year":"2024","unstructured":"Ilagan-Ying YC, Gordon KS, Tate JP, Lim JK, Torgersen J, Lo Re V III, Justice AC, Taddei TH. Risk score for hepatocellular cancer in adults without viral hepatitis or cirrhosis. JAMA Netw Open. 2024;7:e2443608.","journal-title":"JAMA Netw Open"},{"key":"3323_CR43","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.jceh.2024.102446","volume":"15","author":"SP Singh","year":"2025","unstructured":"Singh SP, Madke T, Chand P. Global epidemiology of hepatocellular carcinoma. J Clin Exp Hepatol. 2025;15:102446.","journal-title":"J Clin Exp Hepatol"},{"key":"3323_CR44","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","volume":"52","author":"MS Shiels","year":"2009","unstructured":"Shiels MS, Cole SR, Kirk GD, Poole C. A Meta-Analysis of the incidence of Non-AIDS cancers in HIV-Infected individuals. JAIDS J Acquir Immune Defic Syndr. 2009;52:611.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"3323_CR45","first-page":"943","volume":"35","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Xu S, Song M, Huang W, Yan M, Li X. Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis. Cancer Causes Control. 2024;35:943\u201353.","journal-title":"Cancer Causes Control"},{"key":"3323_CR46","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang W, Wang M, Shi J, Jia X, Dang S. A meta-analysis of statin use and risk of hepatocellular carcinoma. Can J Gastroenterol Hepatol. 2022;2022:5389044.","DOI":"10.1155\/2022\/5389044"},{"key":"3323_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3892\/ijo.2022.5407","volume":"61","author":"W Luo","year":"2022","unstructured":"Luo W, Guo S, Zhou Y, Zhu J, Zhao J, Wang M, Sang L, Wang B, Chang B. Hepatocellular carcinoma: novel Understandings and therapeutic strategies based on bile acids (Review). Int J Oncol. 2022;61:117.","journal-title":"Int J Oncol"},{"key":"3323_CR48","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen K, Li F, et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatol Baltim Md. 2020;71:2050\u201366.","journal-title":"Hepatol Baltim Md"},{"key":"3323_CR49","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","volume":"158","author":"W-H Qin","year":"2020","unstructured":"Qin W-H, Yang Z-S, Li M, et al. High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice. Gastroenterology. 2020;158:1713\u201327.","journal-title":"Gastroenterology"},{"key":"3323_CR50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00125-008-1031-y","volume":"51","author":"MM Joosten","year":"2008","unstructured":"Joosten MM, Beulens JWJ, Kersten S, Hendriks HFJ. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia. 2008;51:1375\u201381.","journal-title":"Diabetologia"},{"key":"3323_CR51","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1001\/jama.287.19.2559","volume":"287","author":"MJ Davies","year":"2002","unstructured":"Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559\u201362.","journal-title":"JAMA"},{"key":"3323_CR52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/sj.ejcn.1602821","volume":"62","author":"JWJ Beulens","year":"2008","unstructured":"Beulens JWJ, de Zoete EC, Kok FJ, Schaafsma G, Hendriks HFJ. Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr. 2008;62:1098\u2013105.","journal-title":"Eur J Clin Nutr"},{"key":"3323_CR53","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3350\/cmh.2020.0203","volume":"26","author":"M Taniai","year":"2020","unstructured":"Taniai M. Alcohol and hepatocarcinogenesis. Clin Mol Hepatol. 2020;26:736\u201341.","journal-title":"Clin Mol Hepatol"},{"key":"3323_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2217\/hep.15.40","volume":"3","author":"IH McKillop","year":"2016","unstructured":"McKillop IH, Schrum LW, Thompson KJ. Role of alcohol in the development and progression of hepatocellular carcinoma. Hepatic Oncol. 2016;3:29\u201343.","journal-title":"Hepatic Oncol"},{"key":"3323_CR55","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(88)92890-5","volume":"2","author":"AG Shaper","year":"1988","unstructured":"Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet Lond Engl. 1988;2:1267\u201373.","journal-title":"Lancet Lond Engl"},{"key":"3323_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.15288\/jsad.2016.77.185","volume":"77","author":"T Stockwell","year":"2016","unstructured":"Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T. Do moderate drinkers have reduced mortality risk? A systematic review and Meta-Analysis of alcohol consumption and All-Cause mortality. J Stud Alcohol Drugs. 2016;77:185\u201398.","journal-title":"J Stud Alcohol Drugs"},{"key":"3323_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102796","author":"Z Liu","year":"2024","unstructured":"Liu Z, Yuan H, Suo C, Zhao R, Jin L, Zhang X, Zhang T, Chen X. Point-based risk score for the risk stratification and prediction of hepatocellular carcinoma: a population-based random survival forest modeling study. eClinicalMedicine. 2024. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102796.","journal-title":"eClinicalMedicine"},{"key":"3323_CR58","doi-asserted-by":"publisher","first-page":"e2421019","DOI":"10.1001\/jamanetworkopen.2024.21019","volume":"7","author":"LA Rodriguez","year":"2024","unstructured":"Rodriguez LA, Schmittdiel JA, Liu L, Macdonald BA, Balasubramanian S, Chai KP, Seo SI, Mukhtar N, Levin TR, Saxena V. Hepatocellular carcinoma in metabolic Dysfunction-Associated steatotic liver disease. JAMA Netw Open. 2024;7:e2421019.","journal-title":"JAMA Netw Open"},{"key":"3323_CR59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3350\/cmh.2024.0145","volume":"30","author":"S Jeong","year":"2024","unstructured":"Jeong S, Oh YH, Ahn JC, et al. Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study. Clin Mol Hepatol. 2024;30:487\u201399.","journal-title":"Clin Mol Hepatol"},{"key":"3323_CR60","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","volume":"9","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Shang Y, Hegmar H, Nasr P. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2024;9:944\u201356.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3323_CR61","doi-asserted-by":"publisher","first-page":"e000572","DOI":"10.1136\/bmjgast-2020-000572","volume":"8","author":"KL Hayward","year":"2021","unstructured":"Hayward KL, Johnson AL, Horsfall LU, Moser C, Valery PC, Powell EE. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterol. 2021;8:e000572.","journal-title":"BMJ Open Gastroenterol"},{"key":"3323_CR62","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3904\/kjim.2024.164","volume":"39","author":"JW Park","year":"2024","unstructured":"Park JW, Yoo J-J, Lee DH, Chang Y, Jo H, Cho YY, Lee S, Kim LY, Jang JY. Evolving epidemiology of non-alcoholic fatty liver disease in South korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022. Korean J Intern Med. 2024;39:931\u201344.","journal-title":"Korean J Intern Med"},{"key":"3323_CR63","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1038\/s41598-023-36214-0","volume":"13","author":"X Liu","year":"2023","unstructured":"Liu X, Morelli D, Littlejohns TJ, Clifton DA, Clifton L. Combining machine learning with Cox models to identify predictors for incident post-menopausal breast cancer in the UK biobank. Sci Rep. 2023;13:9221.","journal-title":"Sci Rep"},{"key":"3323_CR64","doi-asserted-by":"publisher","first-page":"e65286","DOI":"10.2196\/65286","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Wang Y, Li H, Wang L, Zhu J, Yang C, Du L. Development of a prediction model and risk score for Self-Assessment and High-Risk population identification in liver cancer screening: prospective cohort study. JMIR Public Health Surveill. 2024;10:e65286.","journal-title":"JMIR Public Health Surveill"},{"key":"3323_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JHC.S159581","volume":"6","author":"D Geh","year":"2019","unstructured":"Geh D, Rana FA, Reeves HL. Weighing the benefits of hepatocellular carcinoma surveillance against potential harms. J Hepatocell Carcinoma. 2019;6:23\u201330.","journal-title":"J Hepatocell Carcinoma"},{"key":"3323_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ije\/17.2.307","volume":"17","author":"G WANNAMETHEE","year":"1988","unstructured":"WANNAMETHEE G, SHAPER AG. Men who do not drink: A report from the British regional heart study. Int J Epidemiol. 1988;17:307\u201316.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03323-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:02:14Z","timestamp":1770840134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-025-03323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3323"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03323-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7693460\/v1","asserted-by":"object"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Chung-Ang University waived the requirement for both ethical approval and informed consent for this study, as it is a retrospective study that used anonymized data in accordance with the Bioethics and Safety Act (1041078\u2013202112-HR-336\u201301). The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}